Variation in glucuronidation of lamotrigine in human liver microsomes

References

• Anderson GC, Yau MK, Gidal BE, Harris SJ, Levy RH, Lai AA, Wolf KB, Wargin WA, Dren AT. (1996). Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 60:145–56.
   PubMed Web of Science ®Google Scholar
• Argikar UA. (2006). Effects of age, induction, regulation and polymorphisms on the metabolism of antiepileptic drugs. PhD thesis, University of Minnesota, Minneapolis, MN.
   Google Scholar
• Argikar UA, Iwuchukwu OF, Nagar S. (2008). Update on tools for evaluation of uridine diphosphoglucuronosyltransferase polymorphisms. Expert Opin Drug Metab Toxicol 4:879–94.
   PubMed Web of Science ®Google Scholar
• Argikar UA, Remmel RP. (2009). Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of Ugt1a4, Ugt1a8 and Ugt1a10. Drug Metab Dispos 37(1):229–36.
   PubMed Web of Science ®Google Scholar
• Burchell B, Brierley CH, Monaghan G, Clarke DJ. (1998). The structure and function of the UDP-glucuronosyltransferase gene family. Adv Pharmacol 42:335–8.
   PubMedGoogle Scholar
• Chen S, Beaton D, Nguyen N, Senekeo-Effenberger K, Brace-Sinnokrak E, Argikar U, Remmel RP, Trottier J, Barbier O, Ritter JK, Tukey RH. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547–57.
   PubMed Web of Science ®Google Scholar
• Dickins M, Chen C. (2002). Lamotrigine – chemistry, biotransformation and pharmacokinetics. In: Levy RH, Mattson R, Meldrum BS, Perucca E, eds. Antiepileptic drugs, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 371–9.
   Google Scholar
• Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. (1981). Effect of age and gender on disposition of temazepam. J Pharm Sci 70:1104–7.
   PubMed Web of Science ®Google Scholar
• Doig MV, Clare RA. (1991). Use of thermospray liquid chromatography-mass spectrometry to aid in the identification of urinary metabolites of a novel antiepileptic drug, lamotrigine. J Chromatogr 554:181–9.
   PubMed Web of Science ®Google Scholar
• Durnas C, Loi CM, Cusack BJ. (1990). Hepatic drug metabolism and aging. Clin Pharmacokinet 19:359–89.
   PubMed Web of Science ®Google Scholar
• Dutton GJ. (1966). Glucuronic acid – free and combined. New York, NY: Academic Press.
   Google Scholar
• Ethell BT, Anderson GD, Burchell B. (2003). The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol 65:1441–9.
   PubMed Web of Science ®Google Scholar
• Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR. (1998). Glucuronidation of amines and other xenobiotics catalysed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Disp 26:507–12.
   PubMed Web of Science ®Google Scholar
• Green MD, Tephly TR. (1996). Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalysed by expressed human UGT1.4 protein. Drug Metab Dispos 24:356–63.
   PubMed Web of Science ®Google Scholar
• Green MD, Tephly TR. (1998). Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Drug Metab Dispos 26:860–7.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Harmatz JS, MacLaughlin DS, Shader RI. (1981a). Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther 30:475–86.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. (1980). Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther 215:86–91.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, Shader RI. (1981b). Clobazam kinetics in the elderly. Br J Clin Pharmacol 12:631–6.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Shader RI. (1991). Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I). Clin Pharmacokinet 21:165–77.
   PubMed Web of Science ®Google Scholar
• Kolwankar D, Glover DD, Ware JA, Tracy TS. (2005). Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab Dispos 33:524–9.
   PubMed Web of Science ®Google Scholar
• Leach MJ, Randall AD, Stefani A, Hainsworth AH. (2002). Lamotrigine – mechanisms of action. In: Levy RH, Mattson R, Meldrum BS, Perucca E, eds. Antiepileptic drugs, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 363–9.
   Google Scholar
• Maggs JL, Naisbitt DJ, Tettey JN, Pirmohamed M, Park BK. (2000). Metabolism of lamotrigine to a reactive arene oxide intermediate. Chem Res Toxicol 13:1075–81.
   PubMed Web of Science ®Google Scholar
• Nelson MH, Birnbaum AK, Remmel RP. (2001). Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res 44:71–82.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Evangelisti L, Giuliani L, Metelli RM, Giordani R. (1996). Zidovudine glucuronidation in human liver: interindividual variability. Int J Clin Pharmacol Ther 34:329–34.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Gucci A, Giuliani L. (1997). Testosterone sulphation and glucuronidation in the human liver: interindividual variability. Eur J Drug Metab Pharmacokinet 22:253–8.
   PubMed Web of Science ®Google Scholar
• Rambeck B, Wolf P. (1993). Lamotrigine clinical pharmacokinetics. Clin Pharmacokinetic 25:433–43.
   PubMed Web of Science ®Google Scholar
• Remmel RP, Sinz MW. (1991). A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs. In vitro and in vivo studies. Drug Metab Dispos 19:630–6.
   PubMed Web of Science ®Google Scholar
• Rowland A, Elliot DJ, Williams JA, Mackenzie PI, Dickinson RG, Miners JO. (2006). In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine–valproic acid interaction. Drug Metab Dispos 34(6):1055–62.
   PubMed Web of Science ®Google Scholar
• Senekeo-Effenberger K, Chen S, Brace-Sinnokrak E, Bonzo JA, Yueh MF, Argikar U, Kaeding J, Trottier J, Remmel RP, Ritter JK, Barbier O, Tukey RH. (2007). Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor {alpha} activation. Drug Metab Dispos 35:419–27.
   PubMed Web of Science ®Google Scholar
• Sinz MW, Remmel RP. (1991a). Analysis of lamotrigine and lamotrigine 2-N-glucuronide in guinea pig blood and urine by reserved-phase ion-pairing liquid chromatography. J Chromatogr 571:217–30.
   PubMed Web of Science ®Google Scholar
• Sinz MW, Remmel RP. (1991b). Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine. Drug Metab Dispos 19:149–53.
   PubMed Web of Science ®Google Scholar
• Tephly TR, Green MD, Coffman BL, King C, Cheng Z, Rios G. (1998). Metabolism of endobiotics and xenobiotics by UDP-glucuronosyltransferase. Adv Pharmacol 42:343–6.
   PubMedGoogle Scholar
• Vaz AD, Coon MJ, Peegel H, Menon KM. (1992). Substituted pyridines: nonsteroidal inhibitors of human placental aromatase cytochrome P-450. Drug Metab Dispos 20:108–12.
   PubMed Web of Science ®Google Scholar
• Vietri M, Pietrabissa A, Mosca F, Pacifici GM. (2002). Inhibition of mycophenolic acid glucuronidation by niflumic acid in human liver microsomes. Eur J Clin Pharmacol 58:93–7.
   PubMed Web of Science ®Google Scholar
• Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. (1989). The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9:297–301.
   PubMed Web of Science ®Google Scholar